AXA Investment Managers’s Jazz Pharmaceuticals JAZZ Stock Holding History

AXA Investment Managers’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$7.89M	Buy	+59,873	New	+$7.18M	0.02%	464

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AXA Investment Managers's JAZZ Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2025: 59,873 shares worth $7.89M. The stake represents 0.02% of the portfolio and ranks #464 among its holdings.

502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

AXA Investment Managers held 59,873 shares of Jazz Pharmaceuticals worth $7.89M as of Q3 2025.
Jazz Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
Jazz Pharmaceuticals made up 0.02% of AXA Investment Managers's portfolio in Q3 2025, its #464 holding.
502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.